Literature DB >> 34908441

African Swine Fever Virus Regulates Host Energy and Amino Acid Metabolism To Promote Viral Replication.

Qiao Xue1, Huisheng Liu1, Zixiang Zhu1, Fan Yang1, Yingying Song2, Zongqiang Li3, Zhaoning Xue1, Weijun Cao1, Xiangtao Liu1, Haixue Zheng1.   

Abstract

African swine fever is one of the most serious viral diseases caused by African swine fever virus (ASFV). The metabolic changes induced by ASFV infection remain unknown. Here, porcine alveolar macrophages (PAMs) infected with ASFV was analyzed by ultrahigh-performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry (UHPLC-QTOF-MS) in combination with multivariate statistical analysis. A total of 90 metabolites were significantly changed after ASFV infection, and most of them were amino acids and tricarboxylic acid (TCA) cycle intermediates. ASFV infection induced an increase in most of amino acids in the host during the early stages of infection, and amino acids decreased in the late stages of infection. ASFV infection did not significantly affect the glycolysis pathway, whereas it induced increases in citrate, succinate, α-ketoglutarate, and oxaloacetate levels in the TCA cycle, suggesting that ASFV infection promoted the TCA cycle. The activities of aspartate aminotransferase and glutamate production were significantly elevated in ASFV-infected cells and pigs, resulting in reversible transition between TCA cycle and amino acid synthesis. Aspartate, glutamate, and TCA cycle were essential for ASFV replication. In addition, ASFV infection induced an increase in lactate level using lactate dehydrogenase, which led to low expression of beta interferon (IFN-β) and increased ASFV replication. Our data, for the first time, indicate that ASFV infection controls IFN-β production through RIG-I-mediated signaling pathways. These data identified a novel mechanism evolved by ASFV to inhibit host innate immune responses and provide insights for development of new preventive or therapeutic strategies targeting the altered metabolic pathways. IMPORTANCE In order to promote viral replication, viruses often cause severe immunosuppression and seize organelles to synthesize a large number of metabolites required for self-replication. African swine fever virus (ASFV) has developed many strategies to evade host innate immune responses. However, the impact of ASFV infection on host cellular metabolism remains unknown. Here, for the first time, we analyzed the metabolomic profiles of ASFV-infected PAMs. ASFV infection increased host TCA cycle and amino acid metabolism. Aspartate, glutamate, and TCA cycle promoted ASFV replication. ASFV infection also induced the increase of lactate production to inhibit innate immune responses for self-replication. This study identified novel immune evasion mechanisms utilized by ASFV and provided insights into ASFV-host interactions, which is critical for guiding the design of new prevention strategies against ASFV targeting the altered metabolic pathways.

Entities:  

Keywords:  ASFV; RIG-I; TCA cycle; lactate; metabolomics

Mesh:

Substances:

Year:  2021        PMID: 34908441      PMCID: PMC8865428          DOI: 10.1128/JVI.01919-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  62 in total

1.  DDIT3 Targets Innate Immunity via the DDIT3-OTUD1-MAVS Pathway To Promote Bovine Viral Diarrhea Virus Replication.

Authors:  Song Wang; Peili Hou; Wei Pan; Wenqi He; Daniel Chang He; Hongmei Wang; Hongbin He
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

2.  The tricarboxylic acid cycle activity in cultured primary astrocytes is strongly accelerated by the protein tyrosine kinase inhibitor tyrphostin 23.

Authors:  Michaela C Hohnholt; Eva-Maria Blumrich; Helle S Waagepetersen; Ralf Dringen
Journal:  Neurochem Int       Date:  2016-11-25       Impact factor: 3.921

3.  A Cell Culture-Adapted Vaccine Virus against the Current African Swine Fever Virus Pandemic Strain.

Authors:  M V Borca; A Rai; E Ramirez-Medina; E Silva; L Velazquez-Salinas; E Vuono; S Pruitt; N Espinoza; D P Gladue
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

4.  Foot-and-Mouth Disease Virus Viroporin 2B Antagonizes RIG-I-Mediated Antiviral Effects by Inhibition of Its Protein Expression.

Authors:  Zixiang Zhu; Guoqing Wang; Fan Yang; Weijun Cao; Ruoqing Mao; Xiaoli Du; Xiangle Zhang; Chuntian Li; Dan Li; Keshan Zhang; Hongbing Shu; Xiangtao Liu; Haixue Zheng
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

Review 5.  African Swine Fever Virus: A Review.

Authors:  Inmaculada Galindo; Covadonga Alonso
Journal:  Viruses       Date:  2017-05-10       Impact factor: 5.048

Review 6.  African Swine Fever Virus: An Emerging DNA Arbovirus.

Authors:  Natasha N Gaudreault; Daniel W Madden; William C Wilson; Jessie D Trujillo; Juergen A Richt
Journal:  Front Vet Sci       Date:  2020-05-13

7.  Crystal Structure of African Swine Fever Virus dUTPase Reveals a Potential Drug Target.

Authors:  Changyao Li; Yan Chai; Hao Song; Changjiang Weng; Jianxun Qi; Yeping Sun; George F Gao
Journal:  mBio       Date:  2019-10-29       Impact factor: 7.867

8.  African Swine Fever Virus MGF360-12L Inhibits Type I Interferon Production by Blocking the Interaction of Importin α and NF-κB Signaling Pathway.

Authors:  Yisha Zhuo; Zeheng Guo; Tongtong Ba; Cheng Zhang; Lihua He; Cuiping Zeng; Hanchuan Dai
Journal:  Virol Sin       Date:  2020-11-03       Impact factor: 4.327

9.  African Swine Fever Virus Protein pE199L Mediates Virus Entry by Enabling Membrane Fusion and Core Penetration.

Authors:  Tania Matamoros; Alí Alejo; Javier María Rodríguez; Bruno Hernáez; Milagros Guerra; Alberto Fraile-Ramos; Germán Andrés
Journal:  mBio       Date:  2020-08-11       Impact factor: 7.867

View more
  1 in total

1.  Porcine Reproductive and Respiratory Syndrome Virus Adapts Antiviral Innate Immunity via Manipulating MALT1.

Authors:  Han Gu; Suya Zheng; Guangwei Han; Haotian Yang; Zhuofan Deng; Zehui Liu; Fang He
Journal:  mBio       Date:  2022-04-25       Impact factor: 7.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.